Alignment Healthcare Reports Strong Q1 Results, Swings to Profit, and Raises Full-Year Guidance
ALHC sits 78% above its 52-week low of $11.625.
Summary
Alignment Healthcare announced robust first-quarter 2026 financial results, including significant revenue and membership growth, a return to net profitability, and an upward revision of its full-year financial outlook.
Key Events · Earnings and Guidance · ALHC
-
Strong Q1 2026 Financial Performance
Total revenue grew 33.3% year-over-year to $1,235.2 million, with Medicare Advantage membership increasing 30.9% to approximately 284,800 members. Adjusted gross profit rose 36.1% to $145.9 million, and Adjusted EBITDA surged 87.6% to $37.9 million.
-
Return to Net Profitability
The company reported a net income of $11.4 million for Q1 2026, a significant improvement from a net loss of $9.4 million in the prior-year period. Income from operations also turned positive at $15.5 million.
-
Raised Full-Year Guidance
Alignment Healthcare increased the midpoint of its guidance for all key metrics, including membership, total revenue (now $5,160M - $5,205M), adjusted gross profit, and adjusted EBITDA (now $138M - $163M) for fiscal year 2026.
Analysis · ALHC · Finance
Alignment Healthcare's 8-K filing confirms robust first-quarter 2026 financial results, demonstrating significant year-over-year growth in revenue and membership. Crucially, the company swung from a net loss in the prior year to a net income of $11.4 million, indicating improved operational efficiency and profitability. The upward revision of full-year guidance for all key financial metrics signals management's confidence in continued strong performance, providing a positive outlook for investors. While some revenue figures were previously reported by news outlets, this filing provides the complete, official financial statements and detailed guidance, offering a comprehensive view of the company's strong trajectory.
At the time of this filing, ALHC was trading at $20.75 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $11.63 to $23.87. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.